Growth factors in age-related macular degeneration: pathogenic and therapeutic implications.
about
Defining response to anti-VEGF therapies in neovascular AMDTransforming growth factor-β regulates the expression of anosmin (KAL-1) in human retinal pigment epithelial cellsTreatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapyThe mouse retina as an angiogenesis model.Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants.Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat.Emerging biological therapies for age-related macula degeneration.Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularizationRadiation therapy in exudative age-related macular degeneration.Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1.Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and diseaseBreaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration.Age-related macular degeneration: a target for nanotechnology derived medicinesCa2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease.Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration.Influence of preoperative intravitreal bevacizumab on visual function in eyes with proliferative diabetic retinopathy.Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence.Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization.Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways.Carboxyamido-triazole modulates retinal pigment epithelial and choroidal endothelial cell attachment, migration, proliferation, and MMP-2 secretion of choroidal endothelial cells.Genetic association study of age-related macular degeneration in the Spanish population.Homozygosity for the +674C>T polymorphism on VEGF gene is associated with age-related macular degeneration in a Brazilian cohort.Bevacizumab Inhibits Angiogenesis and Inflammation in Rat Filtration Surgery Model.Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model.Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery
P2860
Q26996510-E1AD6B0F-B5EF-4FAE-900D-41C3944B5B45Q28284423-5CDFF2FD-A6B3-4C5A-AA52-2E605D36E036Q28361141-66A3EF5D-6966-418D-8A9E-CDD4654CC29CQ30495106-FDA0A56A-BBFE-417A-805C-9272A1B5E929Q31150795-47E03C3B-987E-4918-921F-6FD85BD000F3Q31931800-4AA37A47-168A-4F27-B99F-F3632CED5EB0Q33224360-50A77199-5833-4E44-A5D7-B82B9BB3FE1DQ33362774-11D4FBD9-7EC8-4C12-BA54-44886F699C9AQ33677016-F534CF34-E3CC-410F-8112-012C461C6D96Q33939846-7BF8B017-90A7-4417-8CC9-3924A8E00161Q33993206-AD5CD159-EF0C-492F-B8AC-025649AFD6BEQ36163917-B9B01B27-EE03-4743-BF47-C458AFA80844Q36178019-88589D75-5873-4507-BFBF-CC6EA5A12918Q36920435-E99695FB-59B6-46F3-B1B7-7A6DCBCB3B45Q37110107-E50B105F-6DB8-4658-9ED0-586E4B5B1C49Q37298565-F0033931-D195-49D4-902C-AA1DE3370841Q38030051-384475A8-41CF-4C0C-B2F7-A2BD8F80638AQ38049554-C7AE3E75-248C-4663-855D-BF00E748A9E1Q38335452-D827D381-EE79-44B3-93CE-5A624E5C45B8Q40870038-5D2C38A6-236A-4C2C-8607-BCDC74E1981FQ41744785-E6237362-3303-44C3-A4A3-CFD176DA9E31Q43789230-8009DEE2-F6B8-4E06-A47A-20589A5000D5Q46425625-D6748DFE-0632-49E7-9040-B4872F0C34DBQ47105600-3D2F4BA2-A5CD-4A05-84D3-9A1E5DCA67A2Q51011627-55B4B0BA-9C79-47C4-BC74-5056BE5C7A51Q51676638-70A118DC-4DF5-463C-AA3C-3B3F6CBE8CCFQ52544785-B7D9BEF7-4780-4711-8651-63CD33A8382FQ54626010-9669667E-470B-4473-A6ED-38198523356DQ57115822-BFB81A8C-A471-496A-AF26-54554F84821B
P2860
Growth factors in age-related macular degeneration: pathogenic and therapeutic implications.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Growth factors in age-related ...... and therapeutic implications.
@en
type
label
Growth factors in age-related ...... and therapeutic implications.
@en
prefLabel
Growth factors in age-related ...... and therapeutic implications.
@en
P356
P1433
P1476
Growth factors in age-related ...... and therapeutic implications.
@en
P2093
P304
P356
10.1159/000268032
P577
1997-01-01T00:00:00Z